Tuesday 23rd April 2024
RAIRDA Survey
Have your say on the way your services are working for your Rare Autoimmune Rheumatic Disease (RAIRD)
A team led by Sabrina Munir at King’s College London has found that the presence of single nucleotide polymorphisms (SNPs) may be indicative of Raynaud's Phenomenon or act as a measure of how likely the individual is to develop the condition.
The degree of constriction experienced by arteries and arterioles relative to their most dilated state is referred to as vascular tone and is maintained by the balance between vasoconstrictors and vasodilators within the blood vessel walls. Vasoconstrictors narrow the blood vessels, decreasing the blood flow, whilst vasodilators widen the blood vessels, increasing the blood flow. In response to the cold, blood vessels will be narrowed. As vascular tone is a critical feature of RP, there has been scientific interest in observing whether genetic variation is causing a shift in the balance between vasoconstrictors and vasodilators in favour of excessive vasoconstriction, thus leading to RP symptoms.
A team led by Sabrina Munir at King's College London examined the effect of single nucleotide polymorphisms (SNPs) in genes which encode temperature-responsive ion channels, vasodilators and vasoconstrictors. An SNP represents the change of a single DNA building block in our genetic blueprint, which could lead to mutations in the gene. The subjects of the study were twins enrolled in the NIHR BRC BioResource TwinsUK adult twin registry.
One SNP in the NOS1 gene was determined as being significantly associated with RP. Furthermore, this variant is present in relevant tissues to RP, such as the skin and the mucosa of the oesophagus. In a healthy body, NOS1 encodes neuronal nitric oxide synthase (nNOS), which is required to produce nitric oxide (NO). NO is a vasodilator and is responsible for mediating vasodilation following exposure to the cold. When NOS1 is mutated, NO is not produced, and so blood vessels remain constricted, leading to limited blood flow and RP symptoms.
There are several potentially useful implications of this result. RP can be difficult to detect in patients, and so the presence of this SNP may be indicative of the presence of the disease or act as a measure of how likely the individual is to develop the disease. Furthermore, this variant may represent a novel therapeutic target, with one possible strategy being to administer NO as a drug to compensate for the lack of it. Research is currently being conducted at the University of Dundee and the University of St Andrews into NO donor drugs to assess their efficacy as vasodilators.
Tuesday 23rd April 2024
Have your say on the way your services are working for your Rare Autoimmune Rheumatic Disease (RAIRD)
Tuesday 19th March 2024
The Scleroderma and Raynaud’s UK sponsored 'Science in Medicine School Teams Prize 2024' contest is now open for entries. The contest aims to engage sixth form school students with science in medicine, and challenges students to prepare an ePoster with a novel vision on how to promote the health and well-being of individuals with Scleroderma and/or Raynaud’s. If you're interested in entering, or know someone in sixth form who might be, read on to find out more!
Wednesday 28th February 2024
As high bills continue to threaten the health of those living with the debilitating condition; SRUK is appealing to energy companies to provide financial assistance to them.